INSURANCE AUSTRALIA GROUP LIMITED (IAG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IAG

IAG - INSURANCE AUSTRALIA GROUP LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Insurance Australia Group is an insurance company formed by the demutualisation of the NRMA Insurance business in July 2000. It is not a customer-facing brand, but an umbrella organisation that holds many well known insurance brands in Australia, NZ and Asia, incl NRMA Insurance and CGU.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$8.98

13 Jun
2025

0.020

OPEN

$9.06

0.22%

HIGH

$9.06

3,105,593

LOW

$8.86

TARGET
$8.794 -2.1% downside
Franking for last dividend paid out: 60%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . MPL . NHF . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
IAG: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 37.3 47.7 xxx
DPS (cps) xxx 27.0 30.7 xxx
EPS Growth xxx 10.0% 27.7% xxx
DPS Growth xxx 80.0% 13.8% xxx
PE Ratio xxx N/A 18.8 xxx
Dividend Yield xxx N/A 3.4% xxx
Div Pay Ratio(%) xxx 72.4% 64.5% xxx

Dividend yield today if purchased 3 years ago: 6.28%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.01

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/08 - ex-div 17c (franking 50%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx37.3
DPS All xxxxxxxxxxxxxxx27.0
Sales/Revenue xxxxxxxxxxxxxxx16,325.0 M
Book Value Per Share xxxxxxxxxxxxxxx281.0
Net Operating Cash Flow xxxxxxxxxxxxxxx1,800.0 M
Net Profit Margin xxxxxxxxxxxxxxx5.50 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx13.49 %
Return on Invested Capital xxxxxxxxxxxxxxx9.58 %
Return on Assets xxxxxxxxxxxxxxx2.96 %
Return on Equity xxxxxxxxxxxxxxx13.49 %
Return on Total Capital xxxxxxxxxxxxxxx16.98 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx703.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx70 M
Long Term Debt xxxxxxxxxxxxxxx2,867 M
Total Debt xxxxxxxxxxxxxxx2,937 M
Goodwill - Gross xxxxxxxxxxxxxxx2,821 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1,841 M
Price To Book Value xxxxxxxxxxxxxxx2.54

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx637.0 M
Capex % of Sales xxxxxxxxxxxxxxx3.90 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx1,873 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx11,695 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

16/05/2025

3

Equal-weight

$7.95

-11.47%

Insurance Australia Group is targeting over 10% EPS accretion from the proposed acquisitions of RACI (RAC Insurance in Western Australia) and RACQ (Royal Automobile Club of Queensland Insurance).

Morgan Stanley sees limited room for error in the plan, highlighting risks to dividend sustainability and the potential need for an equity raising.

While the RACI deal is financially compelling, with around 6.5% EPS accretion expected, execution risk remains high given regulatory hurdles and elevated gearing, caution the analysts.

Equal-weight. Target rises to $7.95 from $7.85. Industry View: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY25 dividend of 33.00 cents and EPS of 47.50 cents.
Morgan Stanley forecasts a full year FY26 dividend of 30.00 cents and EPS of 42.90 cents.

Ord Minnett

xx/xx/xxxx

-1

xx xxxxxx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

02/06/2025

2

Overweight

$8.00

-10.91%

Jarden remains cautious on regulatory risk for Insurance Australia Group's proposed acquisition of RAC, viewing the competitive landscape in Western Australia as more problematic than for the recently approved RACQ deal.

RAC has demonstrated stronger market share growth in WA, notes the broker, and despite lower catastrophe risk and higher profitability, the acquisition would substantially increase market concentration.

The ACCC is expected to weigh improved access to capital for RAC under Insurance Australia Group, but the introduction of cumulative merger assessments from 2026 may complicate approval, suggest the analysts.

Jarden retains a Neutral rating and target price of $8.00.

FORECAST
Jarden forecasts a full year FY25 dividend of 35.00 cents and EPS of 47.50 cents.
Jarden forecasts a full year FY26 dividend of 31.00 cents and EPS of 42.20 cents.

IAG STOCK CHART